Cargando…

Characterizing the metabolic role of STAT3 in canine osteosarcoma

Signal transducer and activator of transcription 3 (STAT3) dysregulation has been characterized in canine OS, with previous data suggesting that constitutive STAT3 activation contributes to survival and proliferation in OS cell lines in vitro. Recently, the contribution of STAT3 to tumour metabolism...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gardner, Heather L., Fenger, Joelle M., Roberts, Ryan D., London, Cheryl A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9669091/ https://www.ncbi.nlm.nih.gov/pubmed/35608271 http://dx.doi.org/10.1111/vco.12841

Ejemplares similares

ΔNp63 mediates cellular survival and metastasis in canine osteosarcoma
por: Cam, Maren, et al.
Publicado: (2016)

Characterization of STAT3 activation and expression in canine and human osteosarcoma
por: Fossey, Stacey L, et al.
Publicado: (2009)

MiR-9 is overexpressed in spontaneous canine osteosarcoma and promotes a metastatic phenotype including invasion and migration in osteoblasts and osteosarcoma cell lines
por: Fenger, Joelle M., et al.
Publicado: (2016)

MiR-34a regulates the invasive capacity of canine osteosarcoma cell lines
por: Lopez, Cecilia M., et al.
Publicado: (2018)

The novel curcumin analog FLLL32 decreases STAT3 DNA binding activity and expression, and induces apoptosis in osteosarcoma cell lines
por: Fossey, Stacey L, et al.
Publicado: (2011)

Canine osteosarcoma genome sequencing identifies recurrent mutations in DMD and the histone methyltransferase gene SETD2
por: Gardner, Heather L., et al.
Publicado: (2019)

Osteosarcoma: Accelerating Progress Makes for a Hopeful Future
por: Saraf, Amanda J., et al.
Publicado: (2018)

Biologic activity of the novel small molecule STAT3 inhibitor LLL12 against canine osteosarcoma cell lines
por: Couto, Jason I, et al.
Publicado: (2012)

The genomic landscape of canine osteosarcoma cell lines reveals conserved structural complexity and pathway alterations
por: Megquier, Kate, et al.
Publicado: (2022)

The selective inhibitor of nuclear export (SINE) verdinexor exhibits biologic activity against canine osteosarcoma cell lines
por: Breitbach, Justin T., et al.
Publicado: (2021)

Target specificity, in vivo pharmacokinetics, and efficacy of the putative STAT3 inhibitor LY5 in osteosarcoma, Ewing's sarcoma, and rhabdomyosarcoma
por: Yu, Peter Y., et al.
Publicado: (2017)

Oncostatin M promotes STAT3 activation, VEGF production, and invasion in osteosarcoma cell lines
por: Fossey, Stacey L, et al.
Publicado: (2011)

Characterization of five newly derived canine osteosarcoma cell lines
por: Wilson-Robles, Heather, et al.
Publicado: (2019)

Characterization of WWOX expression and function in canine mast cell tumors and malignant mast cell lines
por: Makii, Rebecca, et al.
Publicado: (2020)

Plasma cytokeratin‐18 concentrations as noninvasive biomarker of early gastrointestinal toxicosis in dogs receiving toceranib
por: Kovac, Rachel L., et al.
Publicado: (2018)

Morphological and Immunohistochemical Characterization of Canine Osteosarcoma Spheroid Cell Cultures
por: Gebhard, C., et al.
Publicado: (2015)

Safety and efficacy of targeted hyperthermia treatment utilizing gold nanorod therapy in spontaneous canine neoplasia
por: Schuh, Elizabeth M., et al.
Publicado: (2017)

Characterization of receptor tyrosine kinase activation and biological activity of toceranib phosphate in canine urothelial carcinoma cell lines
por: Korec, Daniela I., et al.
Publicado: (2021)

Expression of Bcl-2 in canine osteosarcoma
por: Piro, F., et al.
Publicado: (2015)

Cellular and Phenotypic Characterization of Canine Osteosarcoma Cell Lines
por: Legare, Marie E., et al.
Publicado: (2011)

Plasma Cytokeratin 18 and fecal Alpha‐1 Antitrypsin concentrations in dogs with osteosarcoma receiving carboplatin chemotherapy
por: Taikowski, Kathryn, et al.
Publicado: (2020)

Characterization of STAT3 expression, signaling and inhibition in feline oral squamous cell carcinoma
por: Brown, Megan E., et al.
Publicado: (2015)

Establishment and Characterization of New Canine and Feline Osteosarcoma Primary Cell Lines
por: Meyer, Florian R. L., et al.
Publicado: (2016)

Classical NF-κB Metabolically Reprograms Sarcoma Cells Through Regulation of Hexokinase 2
por: Londhe, Priya, et al.
Publicado: (2018)

STAT3 and its targeting inhibitors in osteosarcoma
por: Liu, Yun, et al.
Publicado: (2020)

Feasibility and safety of whole lung irradiation in the treatment of canine appendicular osteosarcoma
por: Brehm, Amanda, et al.
Publicado: (2021)

Toosendanin demonstrates promising antitumor efficacy in osteosarcoma by targeting STAT3
por: Zhang, T, et al.
Publicado: (2017)

Phase I/II evaluation of RV1001, a novel PI3Kδ inhibitor, in spontaneous canine lymphoma
por: Gardner, Heather L., et al.
Publicado: (2018)

Expression of Nociceptive Ligands in Canine Osteosarcoma
por: Shor, S., et al.
Publicado: (2015)

Safety evaluation of the canine osteosarcoma vaccine, live Listeria vector
por: Musser, Margaret L., et al.
Publicado: (2020)

Molecular Mechanisms of Canine Osteosarcoma Metastasis
por: Wilk, Sylwia S., et al.
Publicado: (2021)

The Prognostic Role of Preoperative Hematological and Inflammatory Indices in Canine Appendicular Osteosarcoma
por: Rigas, Konstantinos, et al.
Publicado: (2023)

Association of Canine Osteosarcoma and Monocyte Phenotype and Chemotactic Function
por: Tuohy, J.L., et al.
Publicado: (2016)

Characterization of IGF2R Molecular Expression in Canine Osteosarcoma as Part of a Novel Comparative Oncology Approach
por: Boisclair, Charles, et al.
Publicado: (2023)

Expression of transferrin receptor‐1 (TFR‐1) in canine osteosarcomas
por: De Vico, Gionata, et al.
Publicado: (2020)

Isolation and Characterization of Novel Canine Osteosarcoma Cell Lines from Chemotherapy-Naïve Patients
por: Leitner, Natascha, et al.
Publicado: (2023)

Evaluation of P16 expression in canine appendicular osteosarcoma
por: Murphy, B. G., et al.
Publicado: (2017)

Molecular Characterisation of Canine Osteosarcoma in High Risk Breeds
por: Simpson, Siobhan, et al.
Publicado: (2020)

Baseline tumor gene expression signatures correlate with chemoimmunotherapy treatment responsiveness in canine B cell lymphoma
por: Dittrich, Katherine, et al.
Publicado: (2023)

The Immunotherapy of Canine Osteosarcoma: A Historical and Systematic Review
por: Wycislo, K.L., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_cbmqve3k26lge3l1p23bugj4u1